FDA Inspection
Kedplasma LLCKedplasma LLC – FDA Inspection, Sep 16, 2026
Record Details
This FDA Inspection record concerns Kedplasma LLC, with an inspection on September 16, 2026, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · 718ba1ea-950b-4669-8097-2d0d9b07eb35
Inspection Facts
- Inspection number
- 1292706
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kedplasma LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 23, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 15, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Kedplasma LLC
- FDA Inspection 1106115 - 2019-08-27
- FDA Inspection 963528 - 2016-02-23
- FDA Inspection 847659 - 2013-09-11
- FDA Inspection 706414 - 2011-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.